39
EMF Epidemiology: State of the Science Dr Dr Leeka Kheifets Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects and Standards Harmonization in Asia and Oceania Seoul, South Korea 22-24 October 2001

EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

EMF Epidemiology:State of the Science

Dr Dr Leeka KheifetsLeeka KheifetsHead, Radiation Program World Health Organization

Switzerland

WHO Meeting on EMF Biological Effects and Standards Harmonization in Asia and Oceania Seoul, South Korea22-24 October 2001

Page 2: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

The QuestionsThe Questions

• Driving the issue: leukemia and brain cancer

• New: breast cancer, neurodegenerative and heart disease

• Almost not a question: reproductive outcomes

– CDHS studies?

ELF

Page 3: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Types of Types of Epidemiologic Studies of ELF ExposureEpidemiologic Studies of ELF Exposure

• Residential

– Wire code

– Measurements

• Occupational

• Appliance use

ELF

Page 4: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Pooled Analyses of Childhood LeukemiaPooled Analyses of Childhood Leukemia

• Greenland et al., Epidemiology, 2000– 12 studies with fields; 4 with wire codes

– Not including UK study

– Field studies: 2,656 cases; 7,084 controls– Metric of choice: time-weighted average

• Ahlbom et al., British J. Cancer, 2000– 9 studies with fields; 2 with wire codes

– Including UK study– Field studies: 3,247 cases; 10,400 controls

– Metric of choice: geometric mean

ELF

Page 5: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

0.5

1.0

1.5

2.0

2.5

3.0

<1 >1 - 2 >2 - 3 >3

Magnetic Field (mG)

Od

ds

Rat

io (

±95%

CI)

Results: Greenland et al., 2000Results: Greenland et al., 2000

2,145/6,275318/529 94/150

99/130cases/controls

ELF

Page 6: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

0.5

1.0

1.5

2.0

2.5

3.0

3.5

<1 1-2 2-4 >4

Magnetic Field (mG)

Od

ds

Rat

io (

±95%

CI)

Results: Results: AhlbomAhlbom et al., 2000et al., 2000

44/62104/147233/332

2,866/9,859

cases/controls

ELF

Page 7: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Measured Fields & LeukemiaMeasured Fields & Leukemia

Summary OR? 0.1?T

(ref.)>0.1?T,? 0.2? T

>0.2?T,? 0.3? T

>0.3?T

Without covariate adjusment

Woolf 1.00 1.00(0.82 – 1.21)

0.98(0.68 – 1.40)

1.91(1.37 – 2.67)

Mantel-Haenszel 1.00 0.98(0.82 – 1.19)

0.96(0.67 – 1.36)

1.69(1.21 – 2.35)

Spline 1.00 1.04(0.93 – 1.17)

1.21(1.02 – 1.43)

1.83(1.14 – 2.93)

With covariate adjustment

Woolf 1.00 1.08(0.87 – 1.35)

0.97(0.65 – 1.44)

2.14(1.49 – 3.08)

Mantel-Haenszel 1.00 1.03(0.81 – 1.31)

0.87(0.55 – 1.37)

2.22(1.48 – 3.34)

Greenland et al., 2000

ELF

Page 8: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Pooled Analysis ofPooled Analysis ofChildhood Leukemia StudiesChildhood Leukemia Studies

Relative Risks (95% Confidence Intervals)Exposure

Measurement Calculated Fields All Studies

<0.1 ?T 1.00 1.00 1.00

0.1 - 0.2 ? T 1.05 (0.9 - 1.3) 1.58 (0.8 - 3.3) 1.08 (0.9 - 1.3)

0.2 - 0.4 ? T 1.15 (0.9 - 1.5) 0.79 (0.3 - 2.3) 1.11 (0.8 - 1.5)

>0.4 ?T 1.87 (1.1 - 3.2) 2.13 (0.9 - 4.9) 2.00 (1.3 - 3.1)

Ahlbom et al., 2000

ELF

Page 9: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Conclusions Conclusions -- Pooled AnalysisPooled Analysis

• ? 2-fold increase in risk above 0.3 - 0.4 ?T

• Association more consistent with measured fields than with wire codes

• Attributable fraction estimate ? 3%

• No confounding evident

• Selection bias may be a partial explanation

• Unlikely to be due to random variability

ELF

Page 10: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Childhood Leukemia SummaryChildhood Leukemia Summary

• Childhood leukemia main driver in risk assessments• Recent pooling efforts point to risk at 0.3 - 0.4+?T• Animal studies negative• Ongoing studies

– Germany, Italy, Japan, U.S., UK• Research needs:

– High-exposure studies– Contact currents– Population mixing– Transients– Selection bias

ELF

Page 11: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Pooled & Individual Risk Estimates for Pooled & Individual Risk Estimates for 38 Leukemia Studies38 Leukemia Studies

Occupational Leukemia Meta-Analysis

Kheifets et al.JOEM, 1997

Ris

k E

stim

ate

Year of Publication

ELF

Page 12: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Year of Publication

Pooled & Individual Risk Estimates for Pooled & Individual Risk Estimates for 29 Brain Cancer Studies29 Brain Cancer Studies

Occupational Brain Cancer Meta-Analysis

Kheifets et al.JOEM, 1995

Rel

ativ

e R

isk

ELF

Page 13: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Year of Publication

Pooled Risk Estimates for Each YearPooled Risk Estimates for Each Year

Cum

ulat

ive

Pool

ed R

elat

ive

Ris

k

Occupational Brain Cancer Meta-Analysis

Kheifets et al.JOEM, 1995

ELF

Page 14: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Occupational Leukemia & Brain CancerOccupational Leukemia & Brain Cancer

• Small risk at the limit of detection

• Few to no studies under way

• Research needs:

– Exposure assessment based on job andenvironment

– Electric fields

– Combining residential and occupational exposure

– Contact current exposure assessment

ELF

Page 15: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Breast CancerBreast Cancer

• Major women’s health (& public health) issue

• Tied (rightfully or wrongfully) to EMF, based mainly on prior laboratory research

• Hypothesis-based

• Epidemiologic studies largely negative– None designed to test the hypothesis

EMF ? Melatonin? Cancer ?? ?

ELF

Page 16: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Breast Cancer SummaryBreast Cancer Summary

• Animal studies inconsistent

– German results not replicated in the U.S.

• MC-7 cells

– Effect seen only in certain type of cells

– Replicated in 3 to 4 laboratories

– Extremely low exposures

ELF

Page 17: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Cardiovascular Disease: Cardiovascular Disease: Lines of EvidenceLines of Evidence

MagneticField

? HRV ? CV Risk+/- +++

Human Lab(overnight)

Epidemiology (+/?)(years – decades)

Clinical/Epidemiology

1985 – 99

ELF

Page 18: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Cardiovascular DiseaseCardiovascular Disease

• Association with acute mortality reported in one study

• HRV reduction in laboratory setting apparently inconsistent

• Two analyses of existing data under way

• Research needs:– Cardiovascular cause-of-death

misclassification on death certificates

ELF

Page 19: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Neurodegenerative DiseasesNeurodegenerative Diseases

• Increasingly geriatric population• Suggested risks associated with occupational

electrical factors (e.g., jobs, shocks)• No prior studies specifically designed to examine

EMF• Little ongoing work

• Research needs:

– Strong methodologic studies looking at electric shocks and other EMF exposures

ELF

Page 20: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

ReproductiveReproductive

• Overall negative epidemiologic and laboratory work

• Two recent analyses point to exposures not previously looked at

• Research needs:

– Evaluate new data

ELF

Page 21: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Risk AssessmentRisk Assessment

Research

RiskCharacterization

Assessment

RELATIVE WEIGHTmost

least

EVIDENCEhuman researchlong-term animal researchshort-term animal researchcell research

Information on Dose:High? Low &

Animal? Human

Human & Laboratory Studies

Field Data & Estimated Exposures; Character-ization of Populations

Hazard Identification

Exposure Assessment

Dose-Response Assessment

Page 22: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

IARC MonographsIARC Monographs

• Initiated in 1969• Criteria established in 1971, last update 1992 • Limited largely to the first step in risk assessment• “Carcinogen”: exposure that is capable of increasing the

incidence of malignant neoplasms (at any stage of thecarcinogenesis)

• No recommendation is given with regard to regulation of legislation, as they are the responsibility of governments or other international organizations

• EMF - Volume #80• 800+ agents have been evaluated

Page 23: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

IARC CriteriaIARC Criteria

• For each disease classify human and animal data separately as:

• Sufficient• Limited• Inadequate• Lack of effect

• Integrate the two classifications above (in vitro as support):• Is carcinogenic to humans (Group 1)• Probably is carcinogenic to humans (Group 2A)• Possibly is carcinogenic to humans (Group 2B)• Not classifiable (Group 3)• Is probably not carcinogenic to humans (Group 4)

Page 24: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Limited Evidence ofLimited Evidence of CarcinogenicityCarcinogenicity

A positive association has been observed between exposure to the agent, mixture or exposure circumstance and cancer for which a causal interpretation is considered by the Working Group to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.

Page 25: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Agents Classified by IARC (834)Agents Classified by IARC (834)

Classification ExamplesCarcinogenic to humans (75)(usually based on strong evidence ofcarcinogenicity in humans)

AsbestosMustard gasTobacco (smoked andsmokeless)Gamma radiation

Probably carcinogenic to humans (59)(usually based on strong evidence ofcarcinogenicity in animals)

Diesel engine exhaustSun lampsUV radiationFormaldehyde

Possibly carcinogenic to humans (225)(usually based on evidence in humanswhich is considered credible, but forwhich other explanations could not beruled out)

CoffeeStyreneGasoline engineexhaustWelding fumes

Page 26: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

The Working GroupThe Working Group

Tasks? Ascertain that all appropriate data have been

collected? Select data based on scientific merit? Prepare accurate summary to enable reader to

follow the reasoning? Evaluate results of epidemiologic and

experimental studies? Evaluate data relevant to mechanisms of action? Make overall evaluation of carcinogenicity to

humans

Page 27: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

The Working GroupThe Working Group

Membership

? 23 participants

? Expertise: epidemiology, toxicology, biology, biophysics, statistics, risk assessment, exposure assessment

? 11 countries

Page 28: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

ConclusionsConclusions

•ELF MAGNETIC FIELDS classified as Group 2B “Possible Carcinogenic”

• based on epidemiologic studies of childhood leukemia

• animal data inadequate

•Other exposures and outcomes considered “inadequate to classify”

Page 29: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Types of Types of Epidemiologic Studies of RF ExposureEpidemiologic Studies of RF Exposure

• Populations near antennas and base stations (including cluster studies)

• Occupational/Military personnel studies

• Cell phone users

RF

Page 30: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Critical Exposure Parameters Critical Exposure Parameters in Cell Phone Studiesin Cell Phone Studies

• Number of calls and call duration

• Power level of cell phone

• Left- or right-hand use

• User positioning of phone at the face

• Phone type / model

RF

Page 31: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Studies of General PopulationStudies of General Population

• Mostly studies of clusters next to transmitters

• Focus on leukemia; other cancers include brain and bladder cancer and skin melanoma

• Inconsistent results with few statistically significant findings (childhood leukemia?)

RF

Page 32: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

LimitationsLimitations

• Ecologic fallacy

• Small numbers

• Previously identified clusters

• Potential confounding

• Exposure assessment, exposure assessment, exposure assessment

RF

Page 33: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Occupational Studies of RF ExposureOccupational Studies of RF Exposure

• Few cohort and case-control studies

• Outcomes of interest: leukemia and brain cancer (other outcomes include uveal, testicular, breast and lung cancer)

• Inconsistent, unreplicated results for various cancer types

RF

Page 34: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

LimitationsLimitations

• Job title classification

• Lack of measurements

• Lack of control for potential risk factors

• Use of external comparison groups

RF

Page 35: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Cell Phone StudiesCell Phone Studies

• Three case-control and two cohort studies of cell phone users

• Focus on brain cancer

• Results negative

– Hints of location of tumor and handedness

RF

Page 36: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

LimitationsLimitations

• Crude assessment

• No measurements

• Low usage (?)

• Short latency

• Hospital controls

RF

Page 37: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

ELF ELF -- RF Epidemiology RF Epidemiology Comparative AnalysisComparative Analysis

• Similar:

– High public awareness

• Focus on involuntary exposure from powerlines and antennas

– Potentially large public health impact

– Difficulties in exposure assessment exacerbated by unknown biophysical mechanism

RF

Page 38: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

RF

DifferencesDifferences

ELF Studies

•Much more sophisticated exposure assessment

•More plentiful

•Addressing broader range of outcomes

•Somewhat more consistent

RF Studies

•Severely limited by exposure assessment which is likely to be even more difficult than for ELF

•Evolving technology

•Limited by latency

•Only a few outcomes examined (mostly cancer)

•Limited methodologically

Page 39: EMF Epidemiology - WHO...EMF Epidemiology: State of the Science Dr Leeka Kheifets Head, Radiation Program World Health Organization Switzerland WHO Meeting on EMF Biological Effects

Complexities of EMF ScienceComplexities of EMF Science

• Epidemiology– Large

misclassification– Small risk– Lack of consistency

• Animal studies– Relevant exposure– Right model– Power to detect

small risk

• In Vitro– Lack of robust effect– Replication– Relevance

• Integration– Multidisciplinary

approach needed– Carcinogenesis is a

complex and highly variable process